You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

Details for Patent: 11,400,019


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 11,400,019 protect, and when does it expire?

Patent 11,400,019 protects POSIMIR and is included in one NDA.

This patent has seven patent family members in seven countries.

Summary for Patent: 11,400,019
Title:Sustained release drug delivery systems with reduced impurities and related methods
Abstract: The present disclosure relates to sustained release drug delivery systems. In some cases, a composition comprises an active pharmaceutical agent; at least one of sucrose acetate isobutyrate and a polyorthoester; an organic solvent; and 2,6-dimethylaniline, wherein the 2,6-dimethylaniline is present at a level less than 500 ppm. In some cases, a composition comprises N-oxide of active pharmaceutical agent at a level less than 1 wt %, based on weight of the composition. In some case, a composition comprises metal present at a level less than 5 ppm. Dosage forms and methods are also provided.
Inventor(s): Miksztal; Andrew R. (Palo Alto, CA), Joice; Judy (San Jose, CA), Autio; Susan (San Jose, CA), Davis; Mark P. (Middleton, WI)
Assignee: DURECT CORPORATION (Cupertino, CA)
Application Number:17/504,913
Patent Claim Types:
see list of patent claims
Composition; Compound;

Drugs Protected by US Patent 11,400,019

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Innocoll POSIMIR bupivacaine SOLUTION;INFILTRATION 204803-001 Feb 1, 2021 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 11,400,019

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Brazil 112022013784 ⤷  Sign Up
Canada 3167217 ⤷  Sign Up
China 115666621 ⤷  Sign Up
European Patent Office 4090353 ⤷  Sign Up
Japan 2023515918 ⤷  Sign Up
South Korea 20220140711 ⤷  Sign Up
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.